Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Basal Ganglia Intracerebral Hemorrhage at the Early Stage

The aim of this trial is to investigate whether neuroendoscopic hematoma evacuation combined with early use of methylprednisolone sodium succinate can improve the efficacy and safety in the treatment with that of simple neuroendoscopic surgery alone for patients with spontaneous basal ganglia intracerebral hemorrhage within 24 hours after the onset.

NCT Number	NCT06924983
Lead Sponsor	Yong Jiang
Conditions	Stroke, Intracerebral Hemorrhage Basal Ganglia, Methylprednisolone, Surgery
Enrollment	100 participants
Start Date	2025-05-01
Primary Completion	2026-11-30 (estimated)
Study Completion	2027-01-31 (estimated)
Updated on ClinicalTrials.gov	2025-04-13